gene rearrangement analysis
gene rearrangement analysis is a genetic therapy with 14 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
11 of 11 finished
0.0%
0 ended early
0
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
Genetic Study of Patients and Families With a History of Colorectal Cancer
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
Clinical Trials (14)
DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
Genetic Study of Patients and Families With a History of Colorectal Cancer
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia
Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer
Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma
Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
All 14 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 14